CDC advisers endorse RSV monoclonal antibody for infants, high-risk young children

A panel of advisers to the Centers for Disease Control and Prevention unanimously voted Thursday to recommend wide use among infants and some high-risk children of an antibody designed to protect against RSV, the country’s leading cause of infant hospitalization.